The AMA issued separate codes for subfascial and subcutaneous implantation of a tibial neuromodulation device.
|Articles|October 1, 2003
CMS proposal will cut reimbursement levels by 4.2%
Separate proposed rule addresses overpayment of physician-administeredchemotherapy
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Urology Times
1
Avoiding False Positives on Prostate Cancer PSMA PET Scans
2
Experts review evidence on testosterone and prostate cancer
3
Carotuximab plus apalutamide shows interim PFS benefit in mCRPC
4
Aglatimagene besadenovec shows sustained immune remodeling in localized prostate cancer
5